ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,659, issued on Aug. 11, was assigned to Bausch Health Ireland Ltd. (Dublin).
"Rifaximin liquid formulations" was invented by Arturo J. Angel (Santa Rosa, Calif.), Kasturi R. Pawar (Rohnert Park, Calif.) and Radhakrishnan S. Pillai (Santa Rosa, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions which enhance the intestinal levels of soluble rifaximin, formulations comprising said compositions, and their use in treating one or more bowel related disorders."
The patent was filed on Sept. 24, 2020, under Application No. 17/763,615.
*For further information, including images, charts and tables, please ...